Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neura...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe289d2c0c864031a37e09fb8593c020 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fe289d2c0c864031a37e09fb8593c020 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fe289d2c0c864031a37e09fb8593c0202021-12-02T16:58:06ZPrecisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome10.1038/s41467-019-08841-72041-1723https://doaj.org/article/fe289d2c0c864031a37e09fb8593c0202019-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-08841-7https://doaj.org/toc/2041-1723Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neural organoids.Wenliang ZhuBoya ZhangMengqi LiFan MoTingwei MiYihui WuZhaoqian TengQi ZhouWei LiBaoyang HuNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-18 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Wenliang Zhu Boya Zhang Mengqi Li Fan Mo Tingwei Mi Yihui Wu Zhaoqian Teng Qi Zhou Wei Li Baoyang Hu Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
description |
Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neural organoids. |
format |
article |
author |
Wenliang Zhu Boya Zhang Mengqi Li Fan Mo Tingwei Mi Yihui Wu Zhaoqian Teng Qi Zhou Wei Li Baoyang Hu |
author_facet |
Wenliang Zhu Boya Zhang Mengqi Li Fan Mo Tingwei Mi Yihui Wu Zhaoqian Teng Qi Zhou Wei Li Baoyang Hu |
author_sort |
Wenliang Zhu |
title |
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
title_short |
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
title_full |
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
title_fullStr |
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
title_full_unstemmed |
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome |
title_sort |
precisely controlling endogenous protein dosage in hpscs and derivatives to model foxg1 syndrome |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/fe289d2c0c864031a37e09fb8593c020 |
work_keys_str_mv |
AT wenliangzhu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT boyazhang preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT mengqili preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT fanmo preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT tingweimi preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT yihuiwu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT zhaoqianteng preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT qizhou preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT weili preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome AT baoyanghu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome |
_version_ |
1718382425236570112 |